VerityRank
Retour aux classements
dsm-firmenich AG
Fabricant VérifiéSwitzerland

dsm-firmenich AG

DSM-Firmenich

DSM-Firmenich est un géant mondial des ingrédients pour la parfumerie, la beauté et la nutrition, formé en 2023 par la fusion de DSM (fondée en 1902) et Firmenich (fondée en 1895). Avec des sièges doubles à Kaiseraugst, Suisse et Heerlen, Pays-Bas, le groupe a réalisé un chiffre d'affaires de 12,52 milliards d'euros (2025). Sa division Parfumerie & Beauté a généré 3,76 milliards d'euros avec une m

SwitzerlandEst. 202328,550€12.521 billion (2025)234 production sites, 15 global R&D hubs, 36 creative centersEuronext Amsterdam (DSFIR.AS)Score 96

Nature de l'activité

DSM-Firmenich AG operates 234 production sites worldwide with 15 global R&D hubs and 36 creative centers. The company's manufacturing model integrates precision fermentation, chemical synthesis, and natural extraction under one roof. In cosmetic ingredients, DSM-Firmenich maintains dedicated production lines for vitamins A, B3, C, E, UV filters PARSOL® series, skin bioactives ALPAFLOR®, and peptides. Post-merger, the combined entity leverages DSM's biotechnology expertise with Firmenich's fragrance science to deliver end-to-end active ingredient solutions from lab-scale bioprocessing to industrial fermentation.

Domaines d'activité principaux

Fragrance & Flavor Ingredients — Core Business
• Fine fragrance compounds for luxury and prestige perfume brands
• Natural and synthetic aroma chemicals including captive molecules
• Encapsulation technologies for long-lasting fragrance delivery

Functional Additives — Core Business
• ALPAFLOR plant-based bioactive complexes for skin health
• PENTAPHARM peptides including SYN-COLL and SYN-AKE anti-aging actives
• Vitamin derivatives A, B3, C, E for cosmetic formulations

Botanical Extracts & Oils — Core Business
• Sustainably sourced natural plant extracts with full traceability
• Essential oils and CO2 extracts for premium personal care
• Upcycled botanical ingredients from food industry byproducts

Advanced UV Filters & Photoprotection — Core Business
• PARSOL series broad-spectrum UV absorbers
• Photostable sunscreen actives with optimized sensory profiles
• Mineral and organic hybrid UV protection systems

Classements sectoriels

Rapport d'entreprise

dsm-firmenich AG is a Swiss-Dutch multinational headquartered in Kaiseraugst, Switzerland and Heerlen, Netherlands. Formed in 2023 through the historic merger of DSM and Firmenich, the company generated €12.52 billion in 2025 revenue with 28,550 employees across 234 production sites.

Business Overview

DSM-Firmenich represents the fusion of two century-old industrial powerhouses: DSM's deep expertise in biotechnology, vitamins, and nutritional science, and Firmenich's unparalleled mastery of fragrance creation and natural ingredient sourcing. The Perfumery & Beauty division, which directly serves the cosmetic ingredient market, achieved €3.76 billion in sales in 2025 with organic growth of 3% despite challenging conditions. The division's adjusted EBITDA margin of 21.7% demonstrates the high-value, sticky nature of its product portfolio.

The company's cosmetic ingredient portfolio is exceptionally broad, covering fragrance ingredients, UV filters (PARSOL), anti-aging peptides (SYN-COLL, SYN-AKE), plant extracts (ALPAFLOR), and vitamin derivatives. The merger has unlocked significant synergies, with the company achieving €65 million in cost savings and €100 million in revenue synergies in 2025. DSM-Firmenich has made the strategic decision to divest its Animal Nutrition & Health business for €2.2 billion to focus exclusively on high-margin health, beauty, and nutrition markets.

Key Strengths

• Uniquely integrated biotechnology and fragrance science capabilities
• Industry-leading 21.7% EBITDA margin in Perfumery & Beauty
• Comprehensive IP portfolio spanning peptides, UV filters, and botanicals
• Strategic divestiture of lower-margin businesses to focus on premium beauty ingredients
• 234 production sites providing unmatched manufacturing scale and geographic redundancy

Challenges & Outlook

The post-merger integration process brings inherent complexity, including cultural alignment between Dutch and Swiss organizational models and the dual headquarters structure. The company recorded a €1.9 billion non-cash impairment related to the ANH divestiture. However, with the strategic pivot fully toward health and beauty, DSM-Firmenich is positioned to capture disproportionate value in the rapidly growing bio-based cosmetic ingredient market.

VerityRank Score: 96/100

Score VerityRank

96/ 100

Basé sur la présence sur le marché, l'échelle financière, la capacité opérationnelle et la force de la marque.

Faits marquants

Siège social

Kaiseraugst, Aargau, Switzerland / Heerlen, Limburg, Netherlands

Fondée

2023

Employés

28,550

Usines

234 production sites, 15 global R&D hubs, 36 creative centers

Sources de données et méthodologie

Ce profil d'entreprise est compilé à partir de sources publiquement disponibles, notamment les rapports annuels, les dépôts réglementaires, les communiqués de presse officiels et les bases de données sectorielles vérifiées. Les chiffres financiers reflètent les divulgations de l'exercice fiscal le plus récent et sont recoupés entre plusieurs références indépendantes.

Le Score VerityRank est calculé à l'aide d'un modèle multidimensionnel propriétaire évaluant la présence sur le marché, la force financière, l'échelle opérationnelle, la capacité d'innovation et l'influence de la marque. Les scores individuels sont normalisés par rapport aux pairs du secteur et mis à jour trimestriellement.

Avertissement : Ce profil est fourni à titre informatif uniquement. VerityRank ne donne aucune garantie quant à son exhaustivité ou sa actualité. Ce contenu ne constitue pas un conseil en investissement ni une recommandation.

Références clés : Site officiel , DSM-Firmenich Investor Relations, DSM-Firmenich Annual Report 2025, SpecialChem Top 100